PMI
Picard MedicalยทAMEX
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About PMI
Picard Medical, Inc.
Holding SynCardia,a company that sells FDA approved fully artificial hearts
Healthcare Equipment and Supplies
--
08/29/2025
American Stock Exchange
75
12-31
Common stock
1992 E Silverlake, Tucson AZ
--
Picard Medical, Inc., a holding company, is the sole owner of SynCardia. The company's business is carried out by SynCardia. Their long-term mission is to build a portfolio of medical technology companies active in the cardiovascular sector. They manufacture and market an FDA-approved implantable total artificial heart designed to temporarily replace full function of the human heart in patients with advanced heart failure. Their product development roadmap focuses on developing, manufacturing and commercializing successive generations of SynCardia TAH to further improve clinical outcomes, usability and patient quality of life.
Company Financials
Revenue & Expenses
PMI has released its 2025 Q3 earnings report, with revenue of 1.19M, reflecting a YoY change of 34.73%, and net profit of -10.43M, showing a YoY change of -68.00%. The Sankey diagram below clearly presents PMI's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
